v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net (loss) income $ (28,692) $ (3,598) $ 618,030 $ 46,984  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization     142,339 170,757  
Non-cash operating lease costs     1,402 5,603  
Share-based compensation     36,738 33,676  
Provision for credit losses on accounts receivable     2,785 2,493  
Provision for credit losses on investments 0 17,566 0 17,566  
Deferred income taxes, net     (27,043) 1,167  
Gain on sale of businesses     (860,597) 0  
Long-lived asset impairment     16,561 1,064  
Goodwill impairment 29,550 17,579 84,389 17,579  
Changes in fair value of contingent consideration     124 (2,834)  
Income from equity method investment, net of tax     (4,942) (11,783)  
Gain on investments, net 0 (678) 0 (5,018)  
Other     1,645 1,339  
Decrease (increase) in:          
Accounts receivable     221,734 187,760  
Prepaid expenses and other current assets     (3,575) (10,325)  
Other assets     2,112 14,658  
Increase (decrease) in:          
Accounts payable and accrued expenses     (172,412) (240,398)  
Deferred revenue     2,406 (4,708)  
Other current liabilities     (19,879) (9,594)  
Net cash provided by operating activities     41,817 215,986  
Cash flows from investing activities:          
Purchases of property and equipment     (91,092) (85,888)  
Acquisitions, net of cash received     (8,030) (67,086)  
Distribution from equity method investment     0 10,756  
Proceeds from sale of equity method investment     0 860  
Proceeds from sale of equity investments     0 25,250  
Proceeds from sale of businesses, net of cash divested     1,134,081 0  
Other     (209) (263)  
Net cash provided by (used in) investing activities     1,034,750 (116,371)  
Cash flows from financing activities:          
Repurchase of common stock     (265,043) (113,221)  
Issuance of common stock under employee stock purchase plan     3,477 3,751  
Deferred payments for acquisitions     (8,121) (213)  
Other     (3,059) (1,783)  
Net cash used in financing activities     (272,746) (111,466)  
Effect of exchange rate changes on cash and cash equivalents     (3,152) 9,339  
Net change in cash and cash equivalents     800,669 (2,512)  
Cash and cash equivalents at beginning of period     607,011 505,880 $ 505,880
Cash and cash equivalents at beginning of period associated with discontinued operations     33,234 18,380 18,380
Cash and cash equivalents at beginning of period associated with continuing operations     573,777 487,500 487,500
Cash and cash equivalents at end of period 1,407,680 503,368 1,407,680 503,368 607,011
Cash and cash equivalents at end of period associated with discontinued operations 0 17,304 0 17,304 33,234
Cash and cash equivalents at end of period associated with continuing operations $ 1,407,680 $ 486,064 $ 1,407,680 $ 486,064 $ 573,777